Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) ROCE %: 6.72% (As of Dec. 2025)

What is Laboratorio Farmaceutico Erfo SpA ROCE %?

Laboratorio Farmaceutico Erfo SpA MIL:ERFO +0.85% 68 ROCE % is 6.72% as of Dec. 2025. GuruFocus rates MIL:ERFO with a GF Score™ of 68/100 and a GF Value™ of €2.10 (Significantly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Laboratorio Farmaceutico Erfo SpA's annualized ROCE % for the quarter that ended in Dec. 2025 was 6.72%.

Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Laboratorio Farmaceutico Erfo SpA ROCE % Related Terms

Laboratorio Farmaceutico Erfo SpA ROCE % Historical Data

* Premium members only.

The historical data trend for Laboratorio Farmaceutico Erfo SpA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Farmaceutico Erfo SpA ROCE % Chart

Laboratorio Farmaceutico Erfo SpA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

25.69

12.78

9.25

6.70

12.42

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROCE %	Get a 7-Day Free Trial							4.20	10.31	3.22	17.71	6.72

68GF Score

Laboratorio Farmaceutico Erfo SpA MIL:ERFO

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Laboratorio Farmaceutico Erfo SpA ROCE % Calculation

Laboratorio Farmaceutico Erfo SpA's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	1.104	/	( ( (9.696 - 1.61)	+	(12.046 - 2.361) )	/ 2 )
	=	1.104	/	( (8.086	+	9.685)	/ 2 )
	=	1.104	/	8.8855
	=	12.42 %

Laboratorio Farmaceutico Erfo SpA's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	0.646	/	( ( (12.3 - 2.747)	+	(12.046 - 2.361) )	/ 2 )
	=	0.646	/	( ( 9.553	+	9.685 )	/ 2 )
	=	0.646	/	9.619
	=	6.72 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 6.72% mean?

Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) has a ROCE % of 6.72% as of Dec. 2025.

Is Laboratorio Farmaceutico Erfo SpA's ROCE % too high?

Laboratorio Farmaceutico Erfo SpA's current ROCE % is 6.72%. The Consumer Packaged Goods industry median ROCE % is 8.75. Laboratorio Farmaceutico Erfo SpA's value of 6.72% is 23.2% below this industry median. Overall, Laboratorio Farmaceutico Erfo SpA has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Laboratorio Farmaceutico Erfo SpA's ROCE % compare to KHC and GIS?

Laboratorio Farmaceutico Erfo SpA's ROCE % of 6.72% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.75. Laboratorio Farmaceutico Erfo SpA's value of 6.72% is 23.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Consumer Packaged Goods company?

The median ROCE % among Consumer Packaged Goods companies is 8.75, based on 1,934 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorio Farmaceutico Erfo SpA's current ROCE % of 6.72% is 23.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorio Farmaceutico Erfo SpA's current ROCE % is 6.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Laboratorio Farmaceutico Erfo SpA stock overvalued right now?

Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.10, compared to a current price of €1.18 — trading 43.8% below its estimated fair value. The current ROCE % is 6.72% and 23.2% below the Consumer Packaged Goods industry median of 8.75. Laboratorio Farmaceutico Erfo SpA's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Laboratorio Farmaceutico Erfo SpA (MIL:ERFO), the current ROCE % is 6.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorio Farmaceutico Erfo SpA (MIL:ERFO) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Farmaceutico Erfo SpA stock appears to be undervalued. The current stock price of €1.18 is trading 43.8% below its estimated GF Value™ of €2.10. GuruFocus considers Laboratorio Farmaceutico Erfo SpA to be Significantly Undervalued.

Key valuation signals for MIL:ERFO:

ROCE %: 6.72%
GF Value™: €2.10 vs. price of €1.18 (43.8% below fair value)
GF Score™: 68/100 with 3 warning signs
Industry Position: 23.2% below the Consumer Packaged Goods median

No single metric tells the full story. See the MIL:ERFO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laboratorio Farmaceutico Erfo SpA Business Description

Industry Consumer Defensive Consumer Packaged Goods

Comparable Companies MIL:MS XSWX:NESN XPAR:BN BOG:NUTRESA TSE:2802 NSE:NESTLEIND SHSE:603288 KHC SHSE:600887 GIS SZSE:300999 LSE:ABF SGX:F34 DUB:KRZ HRL MEX:BIMBOA HKSE:00288 MKC TPE:1216 BOM:500825

Address Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049

Website https://www.erfo.it

Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

68GF Score

Get the complete analysis for MIL:ERFO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.18

Price

€2.10

GF Value

View MIL:ERFO Analysis

See ROCE % data for all stocks →